List of works - David Nutt

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

scientific article

Drug harms in the UK: a multicriteria decision analysis

scientific article

Development of a rational scale to assess the harm of drugs of potential misuse

scientific article

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

scientific article

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

scientific article

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study

scientific article published on 01 August 1998

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

scientific article

GABA system dysfunction in autism and related disorders: from synapse to symptoms

scientific article published on 25 July 2012

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

scientific article

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

scientific article (publication date: July 2016)

Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

scientific article

Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach

scientific article published on April 3, 2014

The dopamine theory of addiction: 40 years of highs and lows

scientific article published on April 15, 2015

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

scientific article published in 2014

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology

scientific article

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

scientific article

Tryptophan metabolism in the central nervous system: medical implications

scientific article

Role of GABA in anxiety and depression

scientific article

Neural correlates of the LSD experience revealed by multimodal neuroimaging

scientific article

'Seeing through a glass darkly': casting light on imidazoline 'I' sites

scientific article published in September 1998

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

scientific article published on 8 November 2006

Broadband cortical desynchronization underlies the human psychedelic state

scientific article

Amphetamine, past and present--a pharmacological and clinical perspective

scientific article

Sleep disorders as core symptoms of depression

scientific article

The anxiogenic action of benzodiazepine antagonists

scientific article published in October 1982

Psychotropic drugs, cardiac arrhythmia, and sudden death

scientific article

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology

scientific article published on 12 February 2014

Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men.

scientific article published in August 1991

Unusual interactions of benzodiazepine receptor antagonists.

scientific article published on 01 February 1982

New insights into the role of the GABAA–benzodiazepine receptor in psychiatric disorder

scientific article published on November 1, 2001

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

scientific article published in October 1990

Stratified medicine for mental disorders

scientific article published on 04 October 2013

Relationship of neurotransmitters to the symptoms of major depressive disorder.

scientific article

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study

scientific article

Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain

scientific article published on August 1, 1992

A web-based survey on mephedrone

scientific article published on March 21, 2011

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.

scientific article

Defining substance use disorders: do we really need more than heavy use?

scientific article published on 07 August 2013

Enhanced repertoire of brain dynamical states during the psychedelic experience.

scientific article published on 3 July 2014

Effects of Schedule I drug laws on neuroscience research and treatment innovation

scientific article published on 12 June 2013

Antidepressant-induced jitteriness/anxiety syndrome: systematic review.

scientific article

Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis

scientific article published on 08 October 2012

The effects of elevated endogenous GABA levels on movement-related network oscillations

scientific article published on 27 October 2012

The neuropharmacology of serotonin and noradrenaline in depression.

scientific article

Which antidepressants have demonstrated superior efficacy? A review of the evidence

scientific article

Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.

scientific article published in January 2001

Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography

scientific article

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution

scientific article published on 11 April 2016

Measuring endogenous 5-HT release by emission tomography: promises and pitfalls

scientific article published on 28 July 2010

Serotonin and brain function: a tale of two receptors

scientific article published on August 2017

List of works by David Nutt

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

Drug harms in the UK: a multicriteria decision analysis

Development of a rational scale to assess the harm of drugs of potential misuse

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

GABA system dysfunction in autism and related disorders: from synapse to symptoms

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach

The dopamine theory of addiction: 40 years of highs and lows

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

Tryptophan metabolism in the central nervous system: medical implications

Role of GABA in anxiety and depression

Neural correlates of the LSD experience revealed by multimodal neuroimaging

'Seeing through a glass darkly': casting light on imidazoline 'I' sites

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

Broadband cortical desynchronization underlies the human psychedelic state

Amphetamine, past and present--a pharmacological and clinical perspective

Sleep disorders as core symptoms of depression

The anxiogenic action of benzodiazepine antagonists

Psychotropic drugs, cardiac arrhythmia, and sudden death

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology

Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men.

Unusual interactions of benzodiazepine receptor antagonists.

New insights into the role of the GABAA–benzodiazepine receptor in psychiatric disorder

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

Stratified medicine for mental disorders

Relationship of neurotransmitters to the symptoms of major depressive disorder.

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study

Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain

A web-based survey on mephedrone

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.

Defining substance use disorders: do we really need more than heavy use?

Enhanced repertoire of brain dynamical states during the psychedelic experience.

Effects of Schedule I drug laws on neuroscience research and treatment innovation

Antidepressant-induced jitteriness/anxiety syndrome: systematic review.

Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis

The effects of elevated endogenous GABA levels on movement-related network oscillations

The neuropharmacology of serotonin and noradrenaline in depression.

Which antidepressants have demonstrated superior efficacy? A review of the evidence

Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.

Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution

Measuring endogenous 5-HT release by emission tomography: promises and pitfalls

Serotonin and brain function: a tale of two receptors